Utilization of Distal Embolic Protection in Saphenous Vein Graft Interventions (An Analysis of 19,546 Patients in the American College of Cardiology-National Cardiovascular Data Registry)

American Journal of Cardiology

Volumn 100, Issue 7, 2007, Pages 1114-1118

  Mehta, Sameer K ^a   Frutkin, Andrew D ^a   Milford Beland, Sarah ^b   Klein, Lloyd W ^c   Shaw, Richard E ^d   Weintraub, William S ^e   Krone, Ronald J ^f   Anderson, H Vernon ^g   Kutcher, Michael A ^h   Marso, Steven P ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Sutter Pacific Heart Centers   (United States)

^e Christiana Care Health Systems   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ANGIOCARDIOGRAPHY; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST; DEVICE; DISEASE SEVERITY; DISTAL EMBOLIC PROTECTION DEVICE; EMBOLISM; FEMALE; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SEX DIFFERENCE; TREATMENT OUTCOME; UNITED STATES;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; EMBOLISM; EQUIPMENT AND SUPPLIES; FEMALE; GRAFT OCCLUSION, VASCULAR; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SAPHENOUS VEIN;

EID: 34548601233     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.058     Document Type: Article

References (15)

1. Baim D.S., Wahr D., George B., Leon M.B., Greenberg J., Cutlip D.E., Kaya U., Popma J.J., Ho K.K., and Kuntz R.E. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105 (2002) 1285-1290
2. Stone G.W., Rogers C., Hermiller J., Feldman R., Hall P., Haber R., Masud A., Cambier P., Caputo R.P., Turco M., et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 108 (2003) 548-553
3. Cohen D.J., Murphy S.A., Baim D.S., Lavelle T.A., Berezin R.H., Cutlip D.E., Ho K.K., and Kuntz R.E. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol 44 (2004) 1801-1808
4. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neil W.W., Schaff H.V., Whitlow P.L., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) e166-e286
5. Webb L.A., Dixon S.R., Safian R.D., and O'Neill W.W. Usefulness of embolic protection devices during saphenous vein graft intervention in a nonselected population. J Interv Cardiol 18 (2005) 73-75
6. Mathew V., Lennon R.J., Rihal C.S., Bresnahan J.F., and Holmes Jr. D.R. Applicability of distal protection for aortocoronary vein graft interventions in clinical practice. Cathet Cardiovasc Intervent 63 (2004) 148-151
7. Brindis R.G., Fitzgerald S., Anderson H.V., Shaw R.E., Weintraub W.S., and Williams J.F. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol 37 (2001) 2240-2245
8. Weintraub W.S., McKay C.R., Riner R.N., Ellis S.G., Frommer P.L., Carmichael D.B., Hammermeister K.E., Effros M.N., Bost J.E., and Bodycombe D.P. The American College of Cardiology National Database: progress and challenges. American College of Cardiology Database Committee. J Am Coll Cardiol 29 (1997) 459-465
9. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 312 (1985) 932-936
10. Moscucci M., Share D., Smith D., O'Donnell M.J., Riba A., McNamara R., Lalonde T., Defranco A.C., Patel K., Rogers E.K., et al. Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database. J Am Coll Cardiol 46 (2005) 625-632
11. Canto J.G., Every N.R., Magid D.J., Rogers W.J., Malmgren J.A., Frederick P.D., French W.J., Tiefenbrunn A.J., Misra V.K., Kiefe C.I., and Barron H.V. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 342 (2000) 1573-1580
12. Magid D.J., Calonge B.N., Rumsfeld J.S., Canto J.G., Frederick P.D., Every N.R., and Barron H.V. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 284 (2000) 3131-3138
13. McGrath P.D., Wennberg D.E., Dickens Jr. J.D., Siewers A.E., Lucas F.L., Malenka D.J., Kellett Jr. M.A., and Ryan Jr. T.J. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA 284 (2000) 3139-3144
14. Giugliano G.R., Kuntz R.E., Popma J.J., Cutlip D.E., and Baim D.S. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol 95 (2005) 173-177
15. Hong M.K., Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Kent K.M., Satler L.F., Stone G.W., and Leon M.B. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100 (1999) 2400-2405